These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 34666184

  • 1. Peptide conjugates of 18β-glycyrrhetinic acid as potent inhibitors of α-glucosidase and AGEs-induced oxidation.
    Khan SN, Shaheen F, Aleem U, Sheikh S, Tamfu AN, Ashraf S, Ul-Haq Z, Ullah S, Wahab AT, Choudhary MI, Jahan H.
    Eur J Pharm Sci; 2022 Jan 01; 168():106045. PubMed ID: 34666184
    [Abstract] [Full Text] [Related]

  • 2. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M, Zaib S, Ibrar A, Amjad ST, Shafique Z, Mehsud S, Saeed A, Iqbal J, Khan I.
    Bioorg Chem; 2018 Apr 01; 77():190-202. PubMed ID: 29421697
    [Abstract] [Full Text] [Related]

  • 3. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M, Mohammadi-Khanaposhtani M, Valizadeh Y, Zonouzi A, Faramarzi MA, Kiani M, Biglar M, Larijani B, Hamedifar H, Mahdavi M, Hajimiri MH.
    Med Chem; 2021 Apr 01; 17(3):264-272. PubMed ID: 32851964
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B.
    Bioorg Chem; 2018 Oct 01; 80():288-295. PubMed ID: 29980114
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study.
    Azimi F, Ghasemi JB, Azizian H, Najafi M, Faramarzi MA, Saghaei L, Sadeghi-Aliabadi H, Larijani B, Hassanzadeh F, Mahdavi M.
    Int J Biol Macromol; 2021 Jan 01; 166():1082-1095. PubMed ID: 33157144
    [Abstract] [Full Text] [Related]

  • 6. Comparative study of selective in vitro and in silico BACE1 inhibitory potential of glycyrrhizin together with its metabolites, 18α- and 18β-glycyrrhetinic acid, isolated from Hizikia fusiformis.
    Wagle A, Seong SH, Zhao BT, Woo MH, Jung HA, Choi JS.
    Arch Pharm Res; 2018 Apr 01; 41(4):409-418. PubMed ID: 29532412
    [Abstract] [Full Text] [Related]

  • 7. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P, Razzaghi N, Ghadimi R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Mar 01; 83():161-169. PubMed ID: 30366316
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N, Mohammadi-Khanaposhtani M, Moradi S, Vahidi M, Asadi M, Faramarzi MA, Mahdavi M, Biglar M, Larijani B, Hamedifar H, Hajimiri MH.
    Bioorg Chem; 2020 Jan 01; 95():103482. PubMed ID: 31838286
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, and In Vitro and In Silico α-Glucosidase Inhibitory Studies of 5-Chloro-2-Aryl Benzo[d]thiazoles.
    Shah S, Arshia, Javaid K, Zafar H, Mohammed Khan K, Khalil R, Ul-Haq Z, Perveen S, Iqbal Choudhary M.
    Bioorg Chem; 2018 Aug 01; 78():269-279. PubMed ID: 29614438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-psoriasis effect of 18β-glycyrrhetinic acid by breaking CCL20/CCR6 axis through its vital active group targeting GUSB/ATF2 signaling.
    Wei J, Zhang J, Hu F, Zhang W, Wu Y, Liu B, Lu Y, Li L, Han L, Lu C.
    Phytomedicine; 2024 Jun 01; 128():155524. PubMed ID: 38552435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ultrasonic synthesis of tyramine derivatives as novel inhibitors of α-glucosidase in vitro.
    Siddiqui H, Bashir MA, Javaid K, Nizamani A, Bano H, Yousuf S, Rahman AU, Choudhary MI.
    J Enzyme Inhib Med Chem; 2016 Dec 01; 31(6):1392-403. PubMed ID: 26912275
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
    Saleem F, Kanwal, Khan KM, Chigurupati S, Solangi M, Nemala AR, Mushtaq M, Ul-Haq Z, Taha M, Perveen S.
    Bioorg Chem; 2021 Jan 01; 106():104489. PubMed ID: 33272713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.